ClinicalTrials.Veeva

Menu

A Text Messaging Program to Help Prevent Early Opioid Relapse (PIER1)

University of Pittsburgh logo

University of Pittsburgh

Status

Completed

Conditions

Substance-Related Disorders

Treatments

Behavioral: PIER

Study type

Interventional

Funder types

Other

Identifiers

NCT02846649
PRO15120183

Details and patient eligibility

About

The objective is to determine feasibility and acceptability of a text message (SMS)-based relapse prevention intervention as measured through: (1) study retention and SMS query completion rates and (2) participant ratings of PIER1 interest, perceived efficacy, and ease of use. Methods: A mixed methods study of adult (age >=18) ED patients who seek treatment for opioids and have evidence of dependence based on Rapid Opioid Dependence Screen (RODS) score of >3 and are being discharged to outpatient (community) resources. All participants receive standard of care in the ED, complete a baseline web survey, are asked to text with us for at least 7 days (up to a max of 28 days) and are asked to complete a follow-up phone call between day 8 and 14. Investigators expect preliminary findings to support a relapse prevention intervention delivered through SMS. Based on feedback from this mixed methods study, investigators plan to test a refined SMS program in a randomized trial.

Full description

The vast majority of those with opioid dependence do not receive treatment. This may be due to the limited availability of existing treatment programs and to a range of societal and individual-level barriers, including the stigma associated with identifying oneself as a substance user and difficulty attending a treatment program on a regular basis. Technology-based interventions have potential to help address these barriers and to expand access to evidence-based psychosocial treatment. Automated, computer-based interventions have found high user acceptance and utilization and shown promise in treating substance use disorders. The current study will evaluate a text-message-based psychosocial program called PIER1 (Preventing and Interrupting Early Relapse 1) when delivered to treatment-seeking opioid-dependent emergency department (ED) patients. PIER1 is an interactive program based on the Relapse Prevention Model. It is also informed by cognitive behavioral therapy and motivational interviewing.

Enrollment

20 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 - 60 years
  • Seeking treatment for substance abuse (chief complaint of "detox")
  • English speaking
  • Opioid dependence (nursing history of opioid use + RODS score>3)
  • Ownership of a mobile phone with text messaging
  • Medically and psychologically stable (as determined by the clinician or investigator)

Exclusion criteria

  • No mobile phone ownership or mobile phone without text messaging capabilities
  • Incarcerated/in police custody
  • Being treated for a self-inflicted injury or suicidal ideation (as determined by the clinician)
  • Medical condition affecting cognition (as determined by the clinician or investigator's discretion)
  • Unable to read, speak, or comprehend English (at the clinician or investigator's discretion)
  • Patients who are under the influence of illicit drugs or alcohol (at the clinician or investigator's discretion)

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

PIER Intervention
Experimental group
Description:
The program will help participants learn to recognize the presence of craving and how it can be reduced through environmental, self-regulatory and mood management. Each day, the PIER1 program sends (1) a morning reflection focused on positive thinking, (2) two random prompts assessing severity of craving, (3) feedback specific to managing withdrawal symptoms, mood management, and environmental triggers that are affecting craving, (4) evening assessments of drug use with feedback, (5) goal commitment prompt with feedback, and (6) user-triggered craving assessments with feedback
Treatment:
Behavioral: PIER

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems